Loading clinical trials...
Loading clinical trials...
A Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)
Conditions
Interventions
ELAD System
Standard of Care (Control)
Locations
44
United States
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Sharp Coronado Hospital
Coronado, California, United States
Stanford University Medical Center
Palo Alto, California, United States
Schiff Center for Liver Diseases/University of Miami
Miami, Florida, United States
Piedmont Atlanta Hospital
Atlanta, Georgia, United States
Emory University Hospital
Atlanta, Georgia, United States
Start Date
January 1, 2016
Primary Completion Date
March 1, 2018
Completion Date
September 1, 2018
Last Updated
January 25, 2019
NCT06159244
NCT06285253
NCT06307522
NCT01809132
NCT01471028
NCT01937130
Lead Sponsor
Vital Therapies, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions